Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
The Tohoku Journal of Experimental Medicine|December 6, 2006
Dose modification of imatinib by monitoring the level of BCR-ABL transcript in chronic myelogenous leukemiaIzumi Ishikawa, Chiaki Kato, Hideo Harigae, et al.
International Journal of Hematology|June 23, 2009
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host diseaseTakanori Teshima, Koji Nagafuji, Hideho Henzan, et al.
Blood Cell Therapy|January 30, 2023
Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignanciesTakahiko Sato, Naomi Kawashima, Masafumi Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2012
Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignanciesJ Luis Espinoza, Akiyoshi Takami, Makoto Onizuka, et al.
The Tohoku Journal of Experimental Medicine|April 26, 2012
Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantationMinami Yamada-Fujiwara, Koichi Miyamura, Tohru Fujiwara, et al.
International Journal of Hematology|June 8, 2006
Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donorYoshihiro Inamoto, Taku Oba, Koichi Miyamura, et al.
International Journal of Hematology|March 16, 2020
Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in JapanAyumi Fujimoto, Ritsuro Suzuki, Katsumi Orihara, et al.
International Journal of Hematology|September 29, 2017
Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegalyKeita Kirito, Kenshi Suzuki, Koichi Miyamura, et al.
International Journal of Hematology|August 24, 2006
Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stem cell transplantationAkiyoshi Takami, Shigeru Shimadoi, Chiharu Sugimori, et al.
Cancer Science|August 13, 2017
Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular responseJunichiro Yuda, Toshihiro Miyamoto, Jun Odawara, et al.
Pageof 15